The first hashish firm to stage an IPO on the London Stock Exchange will this week set up a City veteran as its chairman and unveil a multimillion pound fundraising.

The first hashish firm to stage an IPO on the London Stock Exchange will this week set up a City veteran as its chairman and unveil a multimillion-pound fundraising.

Sky News has learnt that Kanabo Group, which produces medicinal hashish merchandise and operates an NHS-approved telehealth service, will announce on Tuesday that Ian Mattioli will turn into its new non-executive chairman.

Mr Mattioli, co-founder and chief government of the pensions and wealth administration consultancy Mattioli Woods, may even make investments £500,000 in Kanabo shares as a part of a £3m money name.

Existing administration and different shareholders may even take part within the share sale, based on insiders.

He will exchange David Tsur, who has chaired Kanabo because it went public in February 2021 and has now turn into deputy chair.

Read extra:Families urge authorities to fund medical hashish analysisMedical hashish firm Hilltop Leaf secures £2m funding to increase into business gross sales

Mr Mattioli's recruitment is prone to be well-received by buyers who've seen Kanabo's inventory stoop by practically a 3rd over the past 12 months.

The firm now has a market worth of lower than £14m.

It has seen a string of boardroom departures in latest months.

In March, Kanabo launched Treat It, a brand new service centered on continual ache administration utilizing plant-based drugs and coverings unavailable by way of conventional channels.

A spokesman declined to touch upon Mr Mattioli's appointment or its impending fundraising.

Content Source: information.sky.com